US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MiNK Therapeutics, Inc.

11.50

-0.8500-6.88%

Volume:19.89K

Turnover:239.58K

Market Cap:53.98M

PE:-4.04

High:12.38

Open:12.27

Low:11.50

Close:12.35

52wk High:76.00

52wk Low:4.56

Shares:4.69M

Float Shares:1.70M

Volume Ratio:1.20

T/O Rate:1.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8431

EPS(LYR):-2.8582

ROE:-1238.98%

ROA:-69.61%

PB:-3.99

PE(LYR):-4.02

Loading ...

Overview Company News Filings

MiNK Therapeutics Reports MiNK-215 Shows Strong Anti-Tumor Activity in Resistant Solid Tumors

MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases

MiNK Therapeutics Q3 EPS $(0.65) Misses $(0.61) Estimate

MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year

Mink Therapeutics Q3 EPS USD -0.65

THOMSON REUTERS

Mink Therapeutics Inc: Cash Runway Extended Through 2026, Enabling Multiple Inflection Points

THOMSON REUTERS

Mink Therapeutics Reports Q3 2025 Results and Accelerates Inkt Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

THOMSON REUTERS

Press Release: MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

BRIEF-Mink Therapeutics Inc - Files For Mixed Shelf Offering Up To $150 Million - SEC Filing

MiNK Therapeutics files $150M mixed securities shelf

Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

BUZZ-MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers

MiNK Therapeutics reports updated clinical results on agenT-797

MiNK Therapeutics Reports Durable Responses with Allo-iNKT Cell Therapy agenT-797 in Refractory Solid Tumors

Mink Therapeutics Reports Durable Responses and Immune Reactivation With Allo-Inkt Cell Therapy Agent-797 in Pd-1–Refractory Solid Tumors at SITC 2025

THOMSON REUTERS

Mink Therapeutics Inc - Agent-797 Well Tolerated Across All Treated Patients

THOMSON REUTERS

MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development

MiNK Therapeutics Reports Durable Clinical Activity for AgenT-797 in Advanced Solid Tumors

Agenus Secures 10 Million Loan from Zydus Backed by MiNK Therapeutics Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INKT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INKT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":11.5,"timestamp":1764968400000,"preClose":12.35,"halted":0,"volume":19891,"delay":0,"floatShares":1703200,"shares":4694155,"eps":-2.84308,"marketStatus":"Pre-Mkt","change":-0.85,"latestTime":"12-08 05:49:14 EST","open":12.27,"high":12.38,"low":11.5,"amount":239580.252496,"amplitude":0.071255,"askPrice":18.39,"askSize":100,"bidPrice":7.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.84308,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765204200000},"marketStatusCode":1,"adr":0,"listingDate":1634270400000,"exchange":"NASDAQ","adjPreClose":11.5,"postHourTrading":{"tag":"盘后","latestPrice":11.5,"preClose":11.5,"latestTime":"17:50 EST","volume":164,"amount":1891.3,"timestamp":1764975040021},"volumeRatio":1.1957457429025804},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","floatShares":1703200,"roa":"-69.61%","roe":"-1238.98%","lyrEps":-2.858168,"volumeRatio":1.1957457429025804,"shares":4694155,"dividePrice":0,"high":12.38,"amplitude":0.071255,"preClose":12.35,"low":11.5,"week52Low":4.5601,"pbRate":"-3.99","week52High":76,"institutionHeld":0,"latestPrice":11.5,"eps":-2.84308,"divideRate":0,"volume":19891,"delay":0,"ttmEps":-2.84308,"open":12.27,"prevYearClose":6.969,"prevWeekClose":11.5,"prevMonthClose":10.51,"prevQuarterClose":14,"fiveDayClose":10.51,"twentyDayClose":13.66,"sixtyDayClose":14.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INKT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"INKT","fiscalQuarterEnding":"2025/09","expectedEps":-0.86,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-08-14","symbol":"INKT","fiscalQuarterEnding":"2025/06","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2025-05-15","symbol":"INKT","fiscalQuarterEnding":"2025/03","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-03-18","symbol":"INKT","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2025-01-28","symbol":"INKT","defaultRemindTime":1738074600000,"type":"split","dateTimestamp":1738040400000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INKT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INKT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1755234000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INKT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INKT","date":"2025-12-05","current":-4.044909,"percent":0.152174,"low":-37.223699,"twenty":-3.694535,"median":-2.621305,"eighty":-1.66848,"high":-1.078214,"avg":-3.77546,"sd":5.144266,"marketCap":57972814},"quantilePoints":[{"date":"2021-10-15","current":-22.300768,"twenty":-24.056031,"median":-24.056031,"eighty":-23.002873,"marketCap":396052188},{"date":"2021-10-22","current":-22.375104,"twenty":-23.792508,"median":-22.598112,"eighty":-22.330502,"marketCap":397372361},{"date":"2021-10-29","current":-33.246729,"twenty":-24.742333,"median":-23.118463,"eighty":-22.330502,"marketCap":590447803},{"date":"2021-11-05","current":-32.298946,"twenty":-34.406369,"median":-24.056031,"eighty":-22.419706,"marketCap":573615585},{"date":"2021-11-12","current":-30.477717,"twenty":-35.268665,"median":-26.965346,"eighty":-22.575811,"marketCap":541271323},{"date":"2021-11-19","current":-29.69719,"twenty":-35.220347,"median":-29.901613,"eighty":-22.873155,"marketCap":527409497},{"date":"2021-11-26","current":-37.186531,"twenty":-35.22778,"median":-30.91444,"eighty":-23.174215,"marketCap":660417023},{"date":"2021-12-03","current":-13.513422,"twenty":-35.194329,"median":-29.734358,"eighty":-22.315635,"marketCap":351125588},{"date":"2021-12-10","current":-7.891426,"twenty":-35.116276,"median":-26.082607,"eighty":-15.473385,"marketCap":205046622},{"date":"2021-12-17","current":-5.505946,"twenty":-34.540173,"median":-24.056031,"eighty":-10.511586,"marketCap":143063574},{"date":"2021-12-23","current":-6.03462,"twenty":-33.246729,"median":-23.118463,"eighty":-8.665095,"marketCap":156800358},{"date":"2021-12-31","current":-5.750941,"twenty":-32.391866,"median":-22.430856,"eighty":-6.614872,"marketCap":149429401},{"date":"2022-01-07","current":-5.1449,"twenty":-32.298946,"median":-22.282184,"eighty":-5.738047,"marketCap":133682356},{"date":"2022-01-14","current":-4.087552,"twenty":-31.574171,"median":-16.09232,"eighty":-5.544629,"marketCap":106208789},{"date":"2022-01-21","current":-4.02308,"twenty":-31.470101,"median":-14.345117,"eighty":-5.418263,"marketCap":104533572},{"date":"2022-01-28","current":-3.726507,"twenty":-31.369747,"median":-9.761127,"eighty":-5.175847,"marketCap":96827571},{"date":"2022-02-04","current":-4.13913,"twenty":-30.652406,"median":-8.748909,"eighty":-4.652331,"marketCap":107548963},{"date":"2022-02-11","current":-3.597562,"twenty":-30.150639,"median":-6.963023,"eighty":-4.237128,"marketCap":93477136},{"date":"2022-02-18","current":-3.210727,"twenty":-29.80126,"median":-6.369877,"eighty":-4.123657,"marketCap":83425831},{"date":"2022-02-25","current":-3.339672,"twenty":-29.712057,"median":-5.892781,"eighty":-4.061763,"marketCap":86776266},{"date":"2022-03-04","current":-3.752296,"twenty":-28.058084,"median":-5.725152,"eighty":-3.899293,"marketCap":97497658},{"date":"2022-03-11","current":-2.952837,"twenty":-25.906059,"median":-5.557524,"eighty":-3.780663,"marketCap":76724961},{"date":"2022-03-18","current":-3.487668,"twenty":-24.513566,"median":-5.505946,"eighty":-3.726507,"marketCap":105372120},{"date":"2022-03-25","current":-2.72127,"twenty":-24.056031,"median":-5.35766,"eighty":-3.669771,"marketCap":82217100},{"date":"2022-04-01","current":-2.610198,"twenty":-23.660746,"median":-5.183584,"eighty":-3.582088,"marketCap":78861300},{"date":"2022-04-08","current":-3.054487,"twenty":-23.229967,"median":-4.874116,"eighty":-3.378356,"marketCap":92284500},{"date":"2022-04-14","current":-3.254417,"twenty":-22.954924,"median":-4.648462,"eighty":-3.355146,"marketCap":98324940},{"date":"2022-04-22","current":-2.543554,"twenty":-22.620413,"median":-4.332548,"eighty":-3.278852,"marketCap":76847820},{"date":"2022-04-29","current":-2.488018,"twenty":-22.442006,"median":-4.177814,"eighty":-3.202991,"marketCap":75169920},{"date":"2022-05-06","current":-2.165909,"twenty":-22.34537,"median":-4.126236,"eighty":-3.091194,"marketCap":65438100},{"date":"2022-05-13","current":-2.747969,"twenty":-22.293334,"median":-4.087552,"eighty":-2.86808,"marketCap":43293579},{"date":"2022-05-20","current":-2.790574,"twenty":-22.06661,"median":-4.010185,"eighty":-2.747969,"marketCap":43964797},{"date":"2022-05-27","current":-3.557449,"twenty":-19.895501,"median":-3.965054,"eighty":-2.747969,"marketCap":56046726},{"date":"2022-06-03","current":-3.514845,"twenty":-16.711255,"median":-3.829663,"eighty":-2.752229,"marketCap":55375508},{"date":"2022-06-10","current":-3.47224,"twenty":-15.04013,"median":-3.803874,"eighty":-2.773532,"marketCap":54704289},{"date":"2022-06-17","current":-3.429636,"twenty":-14.71261,"median":-3.797427,"eighty":-2.790574,"marketCap":54033071},{"date":"2022-06-24","current":-3.216615,"twenty":-13.732629,"median":-3.778085,"eighty":-2.790574,"marketCap":50676980},{"date":"2022-07-01","current":-2.982292,"twenty":-13.513422,"median":-3.726507,"eighty":-2.811876,"marketCap":46985279},{"date":"2022-07-08","current":-2.811876,"twenty":-10.511586,"median":-3.713612,"eighty":-2.811876,"marketCap":44300406},{"date":"2022-07-15","current":-2.705365,"twenty":-9.224716,"median":-3.680095,"eighty":-2.765011,"marketCap":42622360},{"date":"2022-07-22","current":-2.939688,"twenty":-8.884301,"median":-3.636245,"eighty":-2.786313,"marketCap":46314061},{"date":"2022-07-29","current":-2.790574,"twenty":-8.698621,"median":-3.603705,"eighty":-2.790574,"marketCap":43964797},{"date":"2022-08-05","current":-2.875782,"twenty":-8.04616,"median":-3.557449,"eighty":-2.786313,"marketCap":45307233},{"date":"2022-08-12","current":-1.691835,"twenty":-7.148704,"median":-3.523471,"eighty":-2.747969,"marketCap":57389162},{"date":"2022-08-19","current":-2.588795,"twenty":-6.901129,"median":-3.487668,"eighty":-2.747969,"marketCap":87815189},{"date":"2022-08-26","current":-2.339873,"twenty":-6.669029,"median":-3.423337,"eighty":-2.740426,"marketCap":79371421},{"date":"2022-09-02","current":-2.568881,"twenty":-6.222879,"median":-3.378356,"eighty":-2.707695,"marketCap":87139688},{"date":"2022-09-09","current":-2.777976,"twenty":-6.070724,"median":-3.339672,"eighty":-2.698398,"marketCap":94232453},{"date":"2022-09-16","current":-2.389657,"twenty":-5.864413,"median":-3.318504,"eighty":-2.666174,"marketCap":81060175},{"date":"2022-09-23","current":-1.96151,"twenty":-5.743205,"median":-3.298845,"eighty":-2.620846,"marketCap":66536893},{"date":"2022-09-30","current":-2.100907,"twenty":-5.73031,"median":-3.280522,"eighty":-2.609602,"marketCap":71265404},{"date":"2022-10-07","current":-2.180562,"twenty":-5.686469,"median":-3.259219,"eighty":-2.58847,"marketCap":73967409},{"date":"2022-10-14","current":-1.881855,"twenty":-5.606523,"median":-3.234098,"eighty":-2.550218,"marketCap":63834887},{"date":"2022-10-21","current":-1.971467,"twenty":-5.554945,"median":-3.216615,"eighty":-2.520619,"marketCap":66874644},{"date":"2022-10-28","current":-2.021252,"twenty":-5.529156,"median":-3.196573,"eighty":-2.483575,"marketCap":68563398},{"date":"2022-11-04","current":-3.172412,"twenty":-5.511104,"median":-3.174011,"eighty":-2.476911,"marketCap":82437666},{"date":"2022-11-11","current":-3.900507,"twenty":-5.459526,"median":-3.185989,"eighty":-2.476911,"marketCap":101357787},{"date":"2022-11-18","current":-3.458449,"twenty":-5.397632,"median":-3.210727,"eighty":-2.483575,"marketCap":89870571},{"date":"2022-11-25","current":-3.341434,"twenty":-5.361528,"median":-3.216615,"eighty":-2.488018,"marketCap":86829837},{"date":"2022-12-02","current":-3.276425,"twenty":-5.328002,"median":-3.243208,"eighty":-2.488018,"marketCap":85140541},{"date":"2022-12-09","current":-3.256923,"twenty":-5.260951,"median":-3.250422,"eighty":-2.492461,"marketCap":84633752},{"date":"2022-12-16","current":-2.951383,"twenty":-5.16811,"median":-3.250422,"eighty":-2.513454,"marketCap":76694058},{"date":"2022-12-23","current":-3.016392,"twenty":-5.108796,"median":-3.232202,"eighty":-2.534948,"marketCap":78383355},{"date":"2022-12-30","current":-3.393441,"twenty":-4.98243,"median":-3.216615,"eighty":-2.536669,"marketCap":88181274},{"date":"2023-01-06","current":-3.07958,"twenty":-4.693593,"median":-3.216615,"eighty":-2.543554,"marketCap":80025351},{"date":"2023-01-13","current":-3.068398,"twenty":-4.65491,"median":-3.196573,"eighty":-2.543554,"marketCap":79734792},{"date":"2023-01-20","current":-2.964385,"twenty":-4.644594,"median":-3.175339,"eighty":-2.55244,"marketCap":77031918},{"date":"2023-01-27","current":-2.912378,"twenty":-4.6317,"median":-3.165559,"eighty":-2.566037,"marketCap":75680480},{"date":"2023-02-03","current":-2.886375,"twenty":-4.391863,"median":-3.100903,"eighty":-2.568881,"marketCap":75004762},{"date":"2023-02-10","current":-2.860371,"twenty":-4.308927,"median":-3.0814,"eighty":-2.584163,"marketCap":74329043},{"date":"2023-02-17","current":-2.743356,"twenty":-4.254433,"median":-3.073989,"eighty":-2.588633,"marketCap":71288310},{"date":"2023-02-24","current":-2.743356,"twenty":-4.226813,"median":-3.067501,"eighty":-2.588795,"marketCap":71288310},{"date":"2023-03-03","current":-2.788862,"twenty":-4.170077,"median":-3.024896,"eighty":-2.588795,"marketCap":72470817},{"date":"2023-03-10","current":-2.600338,"twenty":-4.131394,"median":-3.011688,"eighty":-2.595721,"marketCap":67571858},{"date":"2023-03-17","current":-2.886375,"twenty":-4.126236,"median":-3.003594,"eighty":-2.600338,"marketCap":75004762},{"date":"2023-03-24","current":-2.435067,"twenty":-4.118499,"median":-3.00339,"eighty":-2.588795,"marketCap":68160482},{"date":"2023-03-31","current":-2.295747,"twenty":-4.110457,"median":-2.990388,"eighty":-2.563815,"marketCap":64260753},{"date":"2023-04-06","current":-2.265461,"twenty":-4.100141,"median":-2.982292,"eighty":-2.543554,"marketCap":63412986},{"date":"2023-04-14","current":-2.750051,"twenty":-4.087552,"median":-2.979839,"eighty":-2.543554,"marketCap":76977261},{"date":"2023-04-21","current":-2.435067,"twenty":-4.061763,"median":-2.972836,"eighty":-2.53839,"marketCap":68160482},{"date":"2023-04-28","current":-2.277575,"twenty":-4.017922,"median":-2.958611,"eighty":-2.534948,"marketCap":63752093},{"date":"2023-05-05","current":-1.514345,"twenty":-4.005027,"median":-2.951383,"eighty":-2.488018,"marketCap":42388360},{"date":"2023-05-12","current":-1.962591,"twenty":-3.994098,"median":-2.948132,"eighty":-2.479557,"marketCap":54935314},{"date":"2023-05-19","current":-2.285931,"twenty":-3.987343,"median":-2.939688,"eighty":-2.4702,"marketCap":59205948},{"date":"2023-05-26","current":-2.578317,"twenty":-3.984034,"median":-2.921883,"eighty":-2.4702,"marketCap":66778802},{"date":"2023-06-02","current":-2.392253,"twenty":-3.975935,"median":-2.912378,"eighty":-2.469312,"marketCap":61959713},{"date":"2023-06-09","current":-2.977026,"twenty":-3.940487,"median":-2.912378,"eighty":-2.466506,"marketCap":77105421},{"date":"2023-06-16","current":-3.189671,"twenty":-3.915769,"median":-2.912378,"eighty":-2.469312,"marketCap":82612951},{"date":"2023-06-23","current":-4.419023,"twenty":-3.919584,"median":-2.921883,"eighty":-2.469312,"marketCap":114453359},{"date":"2023-06-30","current":-2.777671,"twenty":-3.904322,"median":-2.926214,"eighty":-2.471089,"marketCap":71942111},{"date":"2023-07-06","current":-2.658059,"twenty":-3.886829,"median":-2.918386,"eighty":-2.473684,"marketCap":68844126},{"date":"2023-07-14","current":-2.471995,"twenty":-3.851652,"median":-2.909897,"eighty":-2.473961,"marketCap":64025037},{"date":"2023-07-21","current":-2.445414,"twenty":-3.829663,"median":-2.897284,"eighty":-2.471718,"marketCap":63336595},{"date":"2023-07-28","current":-2.219479,"twenty":-3.819347,"median":-2.892724,"eighty":-2.464872,"marketCap":57484845},{"date":"2023-08-04","current":-2.285931,"twenty":-3.803522,"median":-2.886375,"eighty":-2.444319,"marketCap":59205948},{"date":"2023-08-11","current":-2.551736,"twenty":-3.798505,"median":-2.873373,"eighty":-2.438476,"marketCap":66090360},{"date":"2023-08-18","current":-2.217831,"twenty":-3.791455,"median":-2.870703,"eighty":-2.432124,"marketCap":57628921},{"date":"2023-08-25","current":-2.071746,"twenty":-3.780663,"median":-2.857464,"eighty":-2.423268,"marketCap":53833004},{"date":"2023-09-01","current":-1.925661,"twenty":-3.762611,"median":-2.85448,"eighty":-2.404114,"marketCap":50037087},{"date":"2023-09-07","current":-1.938942,"twenty":-3.757454,"median":-2.85448,"eighty":-2.396135,"marketCap":50382170},{"date":"2023-09-15","current":-1.673333,"twenty":-3.736823,"median":-2.84737,"eighty":-2.386511,"marketCap":43480503},{"date":"2023-09-21","current":-1.766296,"twenty":-3.726507,"median":-2.834368,"eighty":-2.339404,"marketCap":45896086},{"date":"2023-09-29","current":-1.673333,"twenty":-3.721349,"median":-2.827272,"eighty":-2.318672,"marketCap":43480503},{"date":"2023-10-06","current":-1.527249,"twenty":-3.708454,"median":-2.811876,"eighty":-2.300255,"marketCap":39684586},{"date":"2023-10-13","current":-1.513968,"twenty":-3.694535,"median":-2.795363,"eighty":-2.295747,"marketCap":39339503},{"date":"2023-10-20","current":-1.394444,"twenty":-3.681128,"median":-2.795363,"eighty":-2.285931,"marketCap":36233752},{"date":"2023-10-27","current":-1.208518,"twenty":-3.676995,"median":-2.795363,"eighty":-2.279759,"marketCap":31402585},{"date":"2023-11-03","current":-1.367884,"twenty":-3.664613,"median":-2.790574,"eighty":-2.259014,"marketCap":35543586},{"date":"2023-11-10","current":-1.474127,"twenty":-3.641403,"median":-2.777976,"eighty":-2.229732,"marketCap":38304252},{"date":"2023-11-17","current":-1.375696,"twenty":-3.636245,"median":-2.773515,"eighty":-2.215242,"marketCap":34073530},{"date":"2023-11-24","current":-1.421532,"twenty":-3.631448,"median":-2.769315,"eighty":-2.196794,"marketCap":35209930},{"date":"2023-12-01","current":-1.463342,"twenty":-3.620276,"median":-2.750051,"eighty":-2.167489,"marketCap":36245517},{"date":"2023-12-08","current":-1.421532,"twenty":-3.61496,"median":-2.748037,"eighty":-2.120821,"marketCap":35209930},{"date":"2023-12-15","current":-1.505152,"twenty":-3.611893,"median":-2.747969,"eighty":-2.096924,"marketCap":37281103},{"date":"2023-12-22","current":-1.407596,"twenty":-3.602476,"median":-2.74342,"eighty":-2.061079,"marketCap":34864735},{"date":"2023-12-29","current":-1.533025,"twenty":-3.589825,"median":-2.743356,"eighty":-2.053113,"marketCap":37971494},{"date":"2024-01-05","current":-1.560898,"twenty":-3.566615,"median":-2.740578,"eighty":-2.045153,"marketCap":38661884},{"date":"2024-01-12","current":-1.365786,"twenty":-3.557735,"median":-2.730355,"eighty":-2.017158,"marketCap":33829149},{"date":"2024-01-19","current":-1.205794,"twenty":-3.544668,"median":-2.72127,"eighty":-1.987398,"marketCap":29866306},{"date":"2024-01-26","current":-1.198547,"twenty":-3.533717,"median":-2.712816,"eighty":-1.962159,"marketCap":29686804},{"date":"2024-02-02","current":-1.252899,"twenty":-3.521746,"median":-2.704351,"eighty":-1.940534,"marketCap":31033066},{"date":"2024-02-09","current":-1.198686,"twenty":-3.514845,"median":-2.684639,"eighty":-1.909187,"marketCap":29690256},{"date":"2024-02-16","current":-1.296103,"twenty":-3.498539,"median":-2.684063,"eighty":-1.809428,"marketCap":32103172},{"date":"2024-02-23","current":-1.292201,"twenty":-3.481497,"median":-2.677362,"eighty":-1.758328,"marketCap":32006517},{"date":"2024-03-01","current":-1.283978,"twenty":-3.466724,"median":-2.665605,"eighty":-1.713175,"marketCap":31802852},{"date":"2024-03-08","current":-1.297496,"twenty":-3.453248,"median":-2.658059,"eighty":-1.673333,"marketCap":32137691},{"date":"2024-03-15","current":-1.240356,"twenty":-3.439123,"median":-2.655201,"eighty":-1.625524,"marketCap":30722390},{"date":"2024-03-22","current":-1.240356,"twenty":-3.424597,"median":-2.639343,"eighty":-1.572402,"marketCap":30722390},{"date":"2024-03-28","current":-1.406017,"twenty":-3.414868,"median":-2.622846,"eighty":-1.553809,"marketCap":31576140},{"date":"2024-04-05","current":-2.070399,"twenty":-3.405409,"median":-2.619412,"eighty":-1.533025,"marketCap":46496735},{"date":"2024-04-12","current":-1.575976,"twenty":-3.40054,"median":-2.613469,"eighty":-1.535435,"marketCap":35393037},{"date":"2024-04-19","current":-1.346841,"twenty":-3.391822,"median":-2.611769,"eighty":-1.524363,"marketCap":30247167},{"date":"2024-04-26","current":-1.346069,"twenty":-3.384366,"median":-2.608709,"eighty":-1.514043,"marketCap":30229817},{"date":"2024-05-03","current":-1.498008,"twenty":-3.380022,"median":-2.600403,"eighty":-1.501581,"marketCap":33642042},{"date":"2024-05-10","current":-1.389682,"twenty":-3.378356,"median":-2.588795,"eighty":-1.491335,"marketCap":31209292},{"date":"2024-05-17","current":-1.753313,"twenty":-3.373572,"median":-2.588389,"eighty":-1.491335,"marketCap":36092143},{"date":"2024-05-24","current":-1.66059,"twenty":-3.354436,"median":-2.568881,"eighty":-1.494743,"marketCap":34183424},{"date":"2024-05-31","current":-1.834832,"twenty":-3.354436,"median":-2.56833,"eighty":-1.498008,"marketCap":37770224},{"date":"2024-06-07","current":-1.873058,"twenty":-3.341434,"median":-2.555438,"eighty":-1.500688,"marketCap":38557104},{"date":"2024-06-14","current":-1.847027,"twenty":-3.340024,"median":-2.551736,"eighty":-1.504259,"marketCap":38021265},{"date":"2024-06-21","current":-1.664007,"twenty":-3.339672,"median":-2.551736,"eighty":-1.510442,"marketCap":34253782},{"date":"2024-06-28","current":-1.778562,"twenty":-3.339672,"median":-2.547918,"eighty":-1.513968,"marketCap":36611904},{"date":"2024-07-05","current":-1.723867,"twenty":-3.326435,"median":-2.543827,"eighty":-1.513968,"marketCap":35485989},{"date":"2024-07-12","current":-1.852765,"twenty":-3.31697,"median":-2.538446,"eighty":-1.514057,"marketCap":38139368},{"date":"2024-07-15","current":-2.141924,"twenty":-3.315431,"median":-2.536697,"eighty":-1.514079,"marketCap":44091755},{"date":"2024-08-02","current":-1.717364,"twenty":-3.315121,"median":-2.534948,"eighty":-1.514132,"marketCap":35352139},{"date":"2024-08-09","current":-1.54907,"twenty":-3.312502,"median":-2.523913,"eighty":-1.514354,"marketCap":31887787},{"date":"2024-08-16","current":-1.894958,"twenty":-3.306069,"median":-2.511866,"eighty":-1.514354,"marketCap":32384771},{"date":"2024-08-23","current":-1.868711,"twenty":-3.302308,"median":-2.493297,"eighty":-1.515328,"marketCap":31936206},{"date":"2024-08-30","current":-1.82776,"twenty":-3.301228,"median":-2.488018,"eighty":-1.519557,"marketCap":31236354},{"date":"2024-09-06","current":-1.82776,"twenty":-3.298845,"median":-2.483526,"eighty":-1.521434,"marketCap":31236354},{"date":"2024-09-13","current":-1.766912,"twenty":-3.282926,"median":-2.476911,"eighty":-1.523641,"marketCap":30196460},{"date":"2024-09-20","current":-1.774547,"twenty":-3.280522,"median":-2.471995,"eighty":-1.527249,"marketCap":30326941},{"date":"2024-09-27","current":-1.758351,"twenty":-3.280522,"median":-2.470422,"eighty":-1.527249,"marketCap":30050163},{"date":"2024-10-04","current":-1.70028,"twenty":-3.280522,"median":-2.465804,"eighty":-1.529841,"marketCap":29057717},{"date":"2024-10-11","current":-1.550126,"twenty":-3.276425,"median":-2.454052,"eighty":-1.533025,"marketCap":26491591},{"date":"2024-10-18","current":-1.55082,"twenty":-3.276425,"median":-2.443589,"eighty":-1.533025,"marketCap":26503453},{"date":"2024-10-25","current":-1.67483,"twenty":-3.265524,"median":-2.435067,"eighty":-1.538558,"marketCap":28622780},{"date":"2024-10-31","current":-1.66812,"twenty":-3.263844,"median":-2.432124,"eighty":-1.543771,"marketCap":28508115},{"date":"2024-11-08","current":-1.700974,"twenty":-3.263424,"median":-2.430317,"eighty":-1.548271,"marketCap":29069579},{"date":"2024-11-15","current":-1.735215,"twenty":-3.263424,"median":-2.420104,"eighty":-1.549915,"marketCap":29654766},{"date":"2024-11-22","current":-1.980018,"twenty":-3.26006,"median":-2.405543,"eighty":-1.550681,"marketCap":27284362},{"date":"2024-11-29","current":-2.102449,"twenty":-3.257841,"median":-2.398723,"eighty":-1.551791,"marketCap":28972373},{"date":"2024-12-06","current":-1.959088,"twenty":-3.255419,"median":-2.390955,"eighty":-1.553261,"marketCap":26996812},{"date":"2024-12-13","current":-1.808124,"twenty":-3.25202,"median":-2.386365,"eighty":-1.553809,"marketCap":24916484},{"date":"2024-12-20","current":-1.435593,"twenty":-3.250422,"median":-2.339482,"eighty":-1.551791,"marketCap":19782897},{"date":"2024-12-27","current":-1.515093,"twenty":-3.250422,"median":-2.334504,"eighty":-1.547282,"marketCap":20878431},{"date":"2025-01-03","current":-2.898739,"twenty":-3.247536,"median":-2.327858,"eighty":-1.549281,"marketCap":39945474},{"date":"2025-01-10","current":-2.23863,"twenty":-3.235994,"median":-2.334504,"eighty":-1.550126,"marketCap":30848980},{"date":"2025-01-17","current":-2.387872,"twenty":-3.232202,"median":-2.339092,"eighty":-1.55082,"marketCap":32905579},{"date":"2025-01-24","current":-2.798574,"twenty":-3.219732,"median":-2.339873,"eighty":-1.552115,"marketCap":38565180},{"date":"2025-01-31","current":-1.981478,"twenty":-3.216615,"median":-2.339482,"eighty":-1.553535,"marketCap":27305345},{"date":"2025-02-07","current":-3.192221,"twenty":-3.216615,"median":-2.365672,"eighty":-1.553809,"marketCap":43989744},{"date":"2025-02-14","current":-2.654432,"twenty":-3.216615,"median":-2.38724,"eighty":-1.553809,"marketCap":36578859},{"date":"2025-02-21","current":-2.834778,"twenty":-3.213082,"median":-2.390955,"eighty":-1.554293,"marketCap":39064081},{"date":"2025-02-28","current":-2.617046,"twenty":-3.202991,"median":-2.398723,"eighty":-1.558161,"marketCap":36063664},{"date":"2025-03-07","current":-2.346714,"twenty":-3.196321,"median":-2.395488,"eighty":-1.560749,"marketCap":32338406},{"date":"2025-03-14","current":-2.294948,"twenty":-3.193458,"median":-2.389657,"eighty":-1.564152,"marketCap":31625059},{"date":"2025-03-21","current":-3.090383,"twenty":-3.190691,"median":-2.392253,"eighty":-1.566782,"marketCap":33329166},{"date":"2025-03-28","current":-3.392734,"twenty":-3.193458,"median":-2.403757,"eighty":-1.568017,"marketCap":36589966},{"date":"2025-04-04","current":-3.218041,"twenty":-3.213082,"median":-2.414574,"eighty":-1.571411,"marketCap":34705930},{"date":"2025-04-11","current":-2.787743,"twenty":-3.202991,"median":-2.426108,"eighty":-1.57489,"marketCap":30065251},{"date":"2025-04-17","current":-2.879687,"twenty":-3.196825,"median":-2.432124,"eighty":-1.577667,"marketCap":31056849},{"date":"2025-04-25","current":-2.75832,"twenty":-3.194076,"median":-2.433596,"eighty":-1.58027,"marketCap":29747940},{"date":"2025-05-02","current":-2.721543,"twenty":-3.191201,"median":-2.435067,"eighty":-1.580778,"marketCap":29351300},{"date":"2025-05-09","current":-2.545304,"twenty":-3.184837,"median":-2.442315,"eighty":-1.584617,"marketCap":27450605},{"date":"2025-05-16","current":-2.640632,"twenty":-3.177217,"median":-2.449399,"eighty":-1.591135,"marketCap":28478694},{"date":"2025-05-23","current":-2.891668,"twenty":-3.175604,"median":-2.461477,"eighty":-1.59475,"marketCap":28161383},{"date":"2025-05-30","current":-2.848592,"twenty":-3.173691,"median":-2.467558,"eighty":-1.596495,"marketCap":27740172},{"date":"2025-06-06","current":-2.983655,"twenty":-3.171041,"median":-2.471533,"eighty":-1.597248,"marketCap":29055439},{"date":"2025-06-13","current":-3.090027,"twenty":-3.162815,"median":-2.474453,"eighty":-1.599877,"marketCap":30091311},{"date":"2025-06-20","current":-3.040954,"twenty":-3.151841,"median":-2.476911,"eighty":-1.604531,"marketCap":29613431},{"date":"2025-06-27","current":-3.04914,"twenty":-3.151841,"median":-2.483526,"eighty":-1.606931,"marketCap":29693144},{"date":"2025-07-03","current":-2.959671,"twenty":-3.147372,"median":-2.488018,"eighty":-1.607759,"marketCap":28821880},{"date":"2025-07-11","current":-3.163738,"twenty":-3.147372,"median":-2.492332,"eighty":-1.616416,"marketCap":30809128},{"date":"2025-07-18","current":-9.515772,"twenty":-3.16693,"median":-2.499125,"eighty":-1.619875,"marketCap":92666525},{"date":"2025-07-25","current":-7.776329,"twenty":-3.180002,"median":-2.517268,"eighty":-1.621437,"marketCap":75727483},{"date":"2025-08-01","current":-6.204692,"twenty":-3.200412,"median":-2.525634,"eighty":-1.622661,"marketCap":60422560},{"date":"2025-08-08","current":-5.181491,"twenty":-3.218054,"median":-2.534948,"eighty":-1.629275,"marketCap":50458417},{"date":"2025-08-15","current":-6.270177,"twenty":-3.250422,"median":-2.538446,"eighty":-1.632968,"marketCap":61060265},{"date":"2025-08-22","current":-5.997593,"twenty":-3.257382,"median":-2.543827,"eighty":-1.638429,"marketCap":67617758},{"date":"2025-08-29","current":-5.94544,"twenty":-3.263844,"median":-2.545304,"eighty":-1.640218,"marketCap":67029778},{"date":"2025-09-05","current":-5.516181,"twenty":-3.278064,"median":-2.551736,"eighty":-1.641884,"marketCap":62190246},{"date":"2025-09-12","current":-5.87724,"twenty":-3.289294,"median":-2.551736,"eighty":-1.647324,"marketCap":66260880},{"date":"2025-09-19","current":-6.158064,"twenty":-3.304249,"median":-2.556215,"eighty":-1.655567,"marketCap":69426929},{"date":"2025-09-26","current":-5.460016,"twenty":-3.321861,"median":-2.568606,"eighty":-1.659671,"marketCap":61557036},{"date":"2025-10-03","current":-6.202193,"twenty":-3.342434,"median":-2.573908,"eighty":-1.660375,"marketCap":69924451},{"date":"2025-10-10","current":-5.837122,"twenty":-3.378356,"median":-2.586724,"eighty":-1.661528,"marketCap":65808587},{"date":"2025-10-17","current":-5.792993,"twenty":-3.391631,"median":-2.588795,"eighty":-1.663151,"marketCap":65311065},{"date":"2025-10-24","current":-5.680663,"twenty":-3.410525,"median":-2.594566,"eighty":-1.663931,"marketCap":64044646},{"date":"2025-10-31","current":-5.556299,"twenty":-3.45894,"median":-2.600468,"eighty":-1.664376,"marketCap":62642538},{"date":"2025-11-07","current":-5.480075,"twenty":-3.514845,"median":-2.609453,"eighty":-1.664777,"marketCap":61783182},{"date":"2025-11-14","current":-5.303557,"twenty":-3.558021,"median":-2.613339,"eighty":-1.665437,"marketCap":59793094},{"date":"2025-11-21","current":-3.982874,"twenty":-3.61496,"median":-2.615129,"eighty":-1.665807,"marketCap":49209445},{"date":"2025-11-28","current":-3.993082,"twenty":-3.636245,"median":-2.617856,"eighty":-1.666732,"marketCap":49335569},{"date":"2025-12-05","current":-4.692156,"twenty":-3.694535,"median":-2.621305,"eighty":-1.66848,"marketCap":57972814}],"updateTime":1765149611273},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INKT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2585156148","title":"MiNK Therapeutics Reports MiNK-215 Shows Strong Anti-Tumor Activity in Resistant Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2585156148","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585156148?lang=en_us&edition=fundamental","pubTime":"2025-11-21 00:42","pubTimestamp":1763656967,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has announced new preclinical research results for its novel therapy, MiNK-215, which targets solid tumors resistant to current immunotherapies. The findings, now published in Cancer Immunology Research, show that MiNK-215-an IL-15-enhanced, FAP-targeting CAR-iNKT cell therapy-can effectively dismantle tumor-protective fibroblast barriers, remodel the tumor microenvironment, and activate multiple immune pathways. In models of lung and microsatellite stable  colorectal cancer, MiNK-215 promoted immune cell infiltration, activated dendritic cells, re-polarized macrophages, and enabled robust anti-tumor activity. As an off-the-shelf, allogeneic therapy, MiNK-215 offers a scalable treatment option for patients with solid tumors that have not responded to conventional immune-based therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL2JCzVp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","INKT","IE00BKPKM429.USD","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","NDAQ","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2583833956","title":"MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2583833956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583833956?lang=en_us&edition=fundamental","pubTime":"2025-11-15 00:55","pubTimestamp":1763139339,"startTime":"0","endTime":"0","summary":"In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on MiNK Therapeutics, with a price target of $35.00. Emily Bo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mink-therapeutics-advancing-clinical-trials-and-strategic-partnerships-to-address-gvhd-and-pulmonary-diseases-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mink-therapeutics-advancing-clinical-trials-and-strategic-partnerships-to-address-gvhd-and-pulmonary-diseases-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2583948509","title":"MiNK Therapeutics Q3 EPS $(0.65) Misses $(0.61) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583948509","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583948509?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:23","pubTimestamp":1763126597,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.61) by 5.69 percent. This is a 41.3 percent decrease over losses of $(0.46) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48862390/mink-therapeutics-q3-eps-0-65-misses-0-61-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT"],"gpt_icon":0},{"id":"2583459505","title":"MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2583459505","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583459505?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:35","pubTimestamp":1763123756,"startTime":"0","endTime":"0","summary":"“This trial reflects the broader momentum of our iNKT platform as we expand into diseases marked by profound immune dysregulation,” said Dr. Terese...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-q3-eps-65c-vs-46c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-q3-eps-65c-vs-46c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT"],"gpt_icon":0},{"id":"2583686505","title":"Mink Therapeutics Q3 EPS USD -0.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2583686505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583686505?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:32","pubTimestamp":1763123532,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nPLX398BF9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2583505685","title":"Mink Therapeutics Inc: Cash Runway Extended Through 2026, Enabling Multiple Inflection Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505685?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA6TXZWL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2583505535","title":"Mink Therapeutics Reports Q3 2025 Results and Accelerates Inkt Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505535?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nTUA6TXZWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2583505358","title":"Press Release: MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505358?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123400,"startTime":"0","endTime":"0","summary":"-- New clinical data show durable remissions and long-tail survivors. -- GVHD trial launching through non-dilutive funding from NIH- and. -- Launching Phase 2+ trial in severe pulmonary disease in US population. -- Added national leaders in pulmonary medicine, trauma, and biodefense join. -- Cash runway extended through 2026, enabling multiple inflection points. -- Durable clinical responses in refractory solid tumors with agenT-797At. SITC 2025, MiNK reported updated clinical data showing sustained tumor. regression and immune reprogramming with its lead asset agenT-797 across. than two years and survival exceeding two and three years in late stage,Center--Madison, MiNK initiated a preclinical and Phase 1 study of. Jenny Gumperz, is supported by the Mary Gooze Clinical Trial and. \"This trial reflects the broader momentum of our iNKT platform as we expand into diseases marked by profound immune dysregulation,\" said Dr. Terese Hammond, Head of Inflammatory and Pulmonary","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581383400","title":"BRIEF-Mink Therapeutics Inc - Files For Mixed Shelf Offering Up To $150 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581383400","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581383400?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:11","pubTimestamp":1762553487,"startTime":"0","endTime":"0","summary":"BRIEF-Mink Therapeutics Inc - Files For Mixed Shelf Offering Up To $150 Million - SEC FilingMink Therapeutics Inc INKT.O:MINK THERAPEUTICS INC - FILES FOR MIXED SHELF OFFERING UP TO $150 MILLION - SEC FILINGSource text: [ID:n0001193125-25-272532]Further company coverage: INKT.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581783263","title":"MiNK Therapeutics files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581783263?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:00","pubTimestamp":1762552818,"startTime":"0","endTime":"0","summary":"16:58 EST MiNK Therapeutics (INKT) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-files-150m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-files-150m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2581883890","title":"Promising Phase 1 Results for MiNK Therapeutics’ agenT-797 Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581883890","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581883890?lang=en_us&edition=fundamental","pubTime":"2025-11-08 01:35","pubTimestamp":1762536937,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on MiNK Therapeutics, retaining the price target of $35.00. Emily Bodnar’s rating i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-1-results-for-mink-therapeutics-agent-797-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-1-results-for-mink-therapeutics-agent-797-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT"],"gpt_icon":0},{"id":"2581882715","title":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive","url":"https://stock-news.laohu8.com/highlight/detail?id=2581882715","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581882715?lang=en_us&edition=fundamental","pubTime":"2025-11-08 00:01","pubTimestamp":1762531314,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton InteractiveEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL6N3WJ0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KKR","MNST","XYZ","NTLA","AIRS","BK4187","RRR","CNH","LDOS","SOLV","CMI","RYTM","TTD","ANIP","GMED","HAE","CEG","OLED","FLGT","GRND","INOD","HL","NEM","VOYG","ABNB","AFRM","FLR","CE","IE00B19Z9Z06.USD","CDE","MCHP","OGN","GIFI","INKT","WEN","TASK","TSYW.SI","FROG","TXG","AKAM","PTON","DKNG"],"gpt_icon":1},{"id":"2581288952","title":"BUZZ-MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2581288952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581288952?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:24","pubTimestamp":1762525443,"startTime":"0","endTime":"0","summary":"BUZZ-MiNK Therapeutics rises after data shows long-lasting remissions in tough cancers** Shares of drug developer MiNK Therapeutics INKT.O rise 2% to $13.93 premarket ** Co says its experimental cell therapy, agenT-797, shows lasting benefits for patients with advanced cancers who had stopped responding to other treatments** INKT says patients who received agenT-797, either alone or with an existing immunotherapy drug, lived for a median of about 23 months** Some patients with tough-to-treat cancers, including testicular, thymoma, and gastric cancers, saw their disease controlled for more than two years - co** Doctors say that one patient with metastatic testicular cancer experienced a complete remission lasting over two years after receiving the combination therapy - INKT** Other patients with different cancers also saw their tumors shrink or stop growing for extended periods, co says** Up to last close, stock up 96% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL4N3WJ19E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581898388","title":"MiNK Therapeutics reports updated clinical results on agenT-797","url":"https://stock-news.laohu8.com/highlight/detail?id=2581898388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581898388?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:05","pubTimestamp":1762524354,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced updated clinical results evaluating agenT-797, alone and in combination with anti-PD-1 therapy, in patients with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-updated-clinical-results-on-agent-797-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-updated-clinical-results-on-agent-797-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581886589","title":"MiNK Therapeutics Reports Durable Responses with Allo-iNKT Cell Therapy agenT-797 in Refractory Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2581886589","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581886589?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:00","pubTimestamp":1762524048,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has announced updated clinical results from a study evaluating its allogeneic invariant natural killer T  cell therapy, agenT-797, both as a monotherapy and in combination with anti-PD-1 therapy. The data, presented at the Society for Immunotherapy of Cancer  Annual Meeting 2025, involved patients with advanced solid tumors that were refractory to all approved treatments, including checkpoint inhibitors. The results demonstrated durable survival, deep and lasting responses, and evidence of immune reactivation, with a reported median overall survival of approximately 23 months when agenT-797 was combined with anti-PD-1 therapy. The therapy showed a favorable safety profile and consistent activity across tumor types, supporting the potential of iNKT cells as a new class of immune-restorative therapy. MiNK Therapeutics plans to advance agenT-797 into Phase 2 studies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intellige","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL5Zs459:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","LU2095319765.USD","NDAQ","BK4139","IE00BKPKM429.USD","INKT","BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU0314104364.USD"],"gpt_icon":0},{"id":"2581888681","title":"Mink Therapeutics Reports Durable Responses and Immune Reactivation With Allo-Inkt Cell Therapy Agent-797 in Pd-1–Refractory Solid Tumors at SITC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888681?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:00","pubTimestamp":1762524007,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA3DN3DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2581599886","title":"Mink Therapeutics Inc - Agent-797 Well Tolerated Across All Treated Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2581599886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581599886?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:00","pubTimestamp":1762524007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA3DN3DK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2581580779","title":"MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2581580779","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581580779?lang=en_us&edition=fundamental","pubTime":"2025-11-05 22:07","pubTimestamp":1762351620,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  05, 2025  (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/05/3181582/0/en/MiNK-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Highlight-Clinical-and-Corporate-Milestones-Advancing-iNKT-Platform-Toward-Pivotal-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","BK4080","BK4231","INKT","BK4139"],"gpt_icon":0},{"id":"2579593142","title":"MiNK Therapeutics Reports Durable Clinical Activity for AgenT-797 in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2579593142","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579593142?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:00","pubTimestamp":1761829258,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has announced that late-breaking data from its ongoing Phase 1 study of AgenT-797, an allogeneic invariant natural killer T  cell therapy, will be presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer  on November 7-9, 2025, in National Harbor, Maryland. The presentation will highlight updated safety and efficacy results demonstrating durable clinical activity of AgenT-797 in patients with advanced solid tumors. The findings will be shared during a poster session by Dr. Benjamin Garmezy, Assistant Director of Genitourinary Research for Sarah Cannon Research Institute at SCRI Oncology Partners.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDLFw57B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","LU0433182093.SGD","HCA","SG9999014005.SGD","IE00B775SV38.USD","LU1150488135.SGD","BK4585","IE00BKPKM429.USD","LU0203345920.USD","NDAQ","LU1084165304.USD","LU0985489474.SGD","BK4504","INKT","LU0878866978.SGD","LU1119994496.HKD","LU2210150020.SGD","LU1489326972.SGD","LU0130102774.USD","SG9999014021.USD","LU0314104364.USD","LU1267930490.SGD","BK4139","LU0068578508.USD","SG9999014039.USD","BK4112","IE00B3QW5Z07.USD","LU0211327993.USD","LU0211328371.USD","LU2210149790.SGD","LU1261432733.SGD","LU0187121727.USD","IE00B64PRP62.GBP","LU1267930573.SGD","BK4185","LU0128525929.USD","LU0310799852.SGD","LU0708994859.HKD","LU2244417387.USD","LU1150488218.USD","IE00B3S45H60.SGD","LU0882574055.USD","IE00BGHQF748.EUR","LU0310800379.SGD","LU0648001328.SGD","LU0114720955.EUR","LU1201861249.SGD","LU0203347892.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2574994021","title":"Agenus Secures 10 Million Loan from Zydus Backed by MiNK Therapeutics Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2574994021","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574994021?lang=en_us&edition=fundamental","pubTime":"2025-10-10 04:06","pubTimestamp":1760040384,"startTime":"0","endTime":"0","summary":"Agenus Inc. has entered into a new Promissory Note Agreement with Zydus Pharmaceuticals  Inc., a subsidiary of Zydus Lifesciences Limited, for up to $10 million. The note, dated October 8, 2025, carries an interest rate of 3.81% per annum and will mature either upon the closing of an Asset Purchase Agreement and Securities Purchase Agreement between the companies or within 10 days of notification if the deals are not consummated. Proceeds from the loan will fund operational expenses for Agenus's Emeryville and Berkeley facilities in the fourth quarter of 2025, with amounts used for these expenses to be forgiven if the transactions close. As collateral, Agenus has pledged 822,910 shares of MiNK Therapeutics, Inc. common stock. The pledge and related control agreement grant certain rights to Zydus in the event of default, and the collateral is expected to be released upon repayment or forgiveness of the note.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL2RSd7X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT","AGEN"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}